Download PDFPDF

4CPS-133 Daratumumab (darzalex) for the treatment of multiple myeloma in a third-level hospital: variability of use and effectiveness
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address